US 11,939,348 B2
Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
Bruce Szczepankiewicz, Worcester, MA (US); and James M. McKearin, Worcester, MA (US)
Assigned to Metro International Biotech, LLC, Worcester, MA (US)
Appl. No. 17/440,849
Filed by Metro International Biotech, LLC, Worcester, MA (US)
PCT Filed Mar. 18, 2020, PCT No. PCT/US2020/023318
§ 371(c)(1), (2) Date Sep. 20, 2021,
PCT Pub. No. WO2020/197882, PCT Pub. Date Oct. 1, 2020.
Application 17/440,849 is a continuation in part of application No. 16/362,130, filed on Mar. 22, 2019, granted, now 10,618,927, issued on Apr. 14, 2020.
Claims priority of provisional application 62/822,456, filed on Mar. 22, 2019.
Prior Publication US 2022/0144880 A1, May 12, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07H 19/048 (2006.01); C07H 21/02 (2006.01)
CPC C07H 19/048 (2013.01) [C07H 21/02 (2013.01)] 19 Claims
 
1. A composition comprising one or more pharmaceutically-acceptable solid excipients and one or more compounds having a structure represented by Formula II:

OG Complex Work Unit Chemistry
wherein m is 2 or 3, and/or salts thereof.